Evaluation & Reporting of Data: How to provide a (robust) study summary
|
|
- Linette Sparks
- 5 years ago
- Views:
Transcription
1 Evaluation & Reporting of Data: How to provide a (robust) study summary Webinar on Information requirements 30 November 2009
2 Evaluation of all available information Step 1: Evaluation of the data quality Relevance Adequacy Reliability Step 2: Selection of key study(ies) for each endpoint Step 3: Drafting (robust) study summaries
3 Evaluate the data 1.1 Relevance 1.2 Adequacy 1.3 Reliability Step 1: Evaluate Klimisch scoring 2. Adequate studies available? NO YES One adequate study YES More than one adequate study Less reliable studies Step 2: Select One key study One clear key study and supporting study(ies) Different/ conflicting adequate information 3. RSS 3. RSS for key study 3. SS for supporting study(ies) WoE 3. RSS for all studies used as part of the Weight of Evidence (WoE) WoE Step 3: Draft
4 Step 1: Evaluation of data quality
5 Step 1: Evaluation of data quality a. Relevance Data and tests are appropriate for a particular hazard identification or risk characterisation Especially following questions should be considered: Has the right/appropriate/suitable test been selected? Is the test substance the same as the registered substance? Has an appropriate organism/species been tested? Is the route of exposure relevant? Has an appropriate doses/concentrations been tested? Were the critical test parameters influencing the endpoint considered adequately?
6 Step 1: Evaluation of data quality b. Adequacy Information is sufficient for the purpose of C&L and/or risk assessment Data should allow clear decision-making: the substance meets the criteria for classification and labelling the substance is a potential PBT/vPvB appropriate DNEL/PNEC values can be derived for risk assessment purposes data is sufficient for specific requirements
7 Step 1: Evaluation of data quality c. Reliability Quality of the study, method, reporting of results and conclusions Reliability can be assessed using Klimisch scoring system 1 = reliable without restrictions 2 = reliable with restriction 3 = not reliable 4 = not assignable For reliability assessment see Guidance R.4.2.
8 Step 1: Evaluation of data quality c. Reliability Klimisch et al = reliable without restrictions: studies or data [...] generated according to generally valid and/or internationally accepted testing guidelines (preferably performed according to GLP) or in which the test parameters documented are based on a specific (national) testing guideline [...] or in which all parameters described are closely related/comparable to a guideline method. For reliability assessment see Guidance R.4.2.
9 Step 1: Evaluation of data quality c. Reliability Klimisch et al = not assignable: studies or data [...] which do not give sufficient experimental details and which are only listed in short abstracts or secondary literature (books, reviews, etc.). For reliability assessment see Guidance R.4.2.
10 Evaluate the data 1.1 Relevance 1.2 Adequacy 1.3 Reliability Step 1: Evaluate Klimisch scoring 2. Adequate studies available? NO YES One adequate study YES More than one adequate study Less reliable studies Step 2: Select One key study One clear key study and supporting study(ies) Different/ conflicting adequate information 3. RSS 3. RSS for key study 3. SS for supporting study(ies) WoE 3. RSS for all studies used as part of the Weight of Evidence (WoE) WoE Step 3: Draft
11 Step 2: Selection of key study
12 Step 2: Selection of key study Key study = study of greatest relevance the most suitable to describe an endpoint the basis for the risk assessment How to select key study(ies) Determine a key study for each endpoint based on the relevance, adequacy & reliability of the study(ies) usually the study which gives highest concern reliability indicator for a key study (Klimisch score) is 1-2
13 Step 2: Selection of key study
14 Evaluate the data 1.1 Relevance 1.2 Adequacy 1.3 Reliability Step 1: Evaluate Klimisch scoring 2. Adequate studies available? NO YES One adequate study YES More than one adequate study Less reliable studies Step 2: Select One key study One clear key study and supporting study(ies) Different/ conflicting adequate information 3. RSS 3. RSS for key study 3. SS for supporting study(ies) WoE 3. RSS for all studies used as part of the Weight of Evidence (WoE) WoE Step 3: Draft
15 Step 3: Drafting a Robust Study Summary WoE WoE 3. RSS 3. RSS for key study 3. SS for supporting study(ies) 3. RSS for all studies used as part of the Weight of Evidence (WoE)
16 Step 3: Drafting a Robust Study Summary (1) A detailed summary of the objectives, methods, results and conclusions of a full study report that provides sufficient information to make an independent assessment of the study, while minimising the need to consult the full study report [see: Article 3 (28)]. Level of detail needed?
17 Step 3: Drafting a Robust Study Summary (2) Robust Study Summary (RSS) contains as many details as necessary: To describe the test protocol and justify the validity of the result To assess the reliability and completeness of the study without having to go back to the full study report To assess whether the correct key study(ies) has/have been chosen for an endpoint IUCLID = Detail level 2 Basic fields + Additional information IUCLID display type = "all fields
18 Step 3: Drafting a Robust Study Summary (3) When is RSS required? if required under Annex I in the technical dossier (Article 10 (a)(vii)) This means: when CSR is required (substances at or above 10 tpa) for key studies
19 Step 3: Drafting a Robust Study Summary (4) RSS is recommended: for all key studies also for substances less than 10 tpa also for physico-chemistry end-points for all studies that are used as part of the Weight of Evidence (WoE) for non-key studies demonstrating a higher concern than a key study when the study gives ambiguous results when the study is performed according to non-standard protocols See: Guidance on registration,
20 Step 3: Drafting a Robust Study Summary (5) When using old studies: Physico-chemical, human health and environmental tests not performed according to test guideline and GLP Historical human data the information should be sufficient for Classification & Labelling and/or risk assessment the information should be scientifically valid adequate documentation must be provided
21 Step 3: Drafting a Robust Study Summary (6) What to provide for old studies: Robust Study Summary to enable ECHA to evaluate this non-standard data Need for justification when used as a key study justification ALWAYS needed Annex XI.1 No justification is needed if the study is submitted as a supportive study More deviations from the standard testing guideline more information needed to enable a good evaluation!!!
22 Step 3: Drafting a Robust Study Summary (7) Use of studies as supporting information: Valid study but reliability lower than that of key study Used in WoE and/or as supportive studies Registrant s specific tasks Report reasons why specific key study has been selected provide Study Summary for supportive studies BUT when supportive study indicates higher concern than the selected key study provide Robust Study Summary for supportive studies
23 Step 3: Drafting a Study Summary (1) A summary of the objectives, methods, results and conclusions of a full study report providing sufficient information to make an assessment of the relevance of the study [see: Article 3 (29)]. Level of detail needed?
24 Step 3: Drafting a Study Summary (2) Level of detail: Less detailed than RSS Information must be provided in sufficient detail to allow evaluation of the relevance of the study IUCLID = Detail level 1 Relevant for all study summaries IUCLID display type "basic fields as defined in the OECD harmonised templates. these fields should be completed for each study summary as far as possible.
25 Step 3: Drafting a Study Summary (3) When to provide: for key studies submitted for registration of substances manufactured/imported at 1-10 t/a (REACH Annex VI and VII) ECHA recommends to provide RSS for supportive studies Unless supportive study shows a higher concern than the key study
26 Experience so far Robust study summary quality show important differences in quality! Frequent errors: validity, reliability, repeatability criteria missing No independent evaluation possible poor reporting of test results Tabular or graphical form preferred unclear or insufficient level of detail on test material justifications for key study selection missing final conclusions at end of endpoint study record
27 Practical IUCLID tips How to fill in a robust study summary in IUCLID 5
28 Practical IUCLID tips When drafting RSS - Use the detail level 'all fields' in IUCLID technical dossier Guidance on registration,
29 Drafting RSS in IUCLID
30 Study Design Details on on inoculum Parameter followed for for biodegradation estimation estimation Details on on analytical methods Details on on study study design design
31 Practical IUCLID tips How to fill in the study summary in IUCLID 5
32 Practical IUCLID tips When drafting Study Summary - Use the detail level basic fields' in the IUCLID technical dossier Guidance on registration,
33 Drafting Study Summary in IUCLID
34 Study Design Any other information on on materials and and methods methods incl. incl. tables tables
35 Key messages and references GOOD DOCUMENTATION necessary for a reliable evaluation Key study Robust study summary References: Guidance on registration IUCLID 5 End User Manual Manual on robust study summaries
How to bring your registration dossier in compliance with REACH Tips and Hints Part 2
How to bring your registration dossier in compliance with REACH Tips and Hints Part 2 Water solubility Pablo Regil ECHA 28 January, 2013 11:00-14:00 Helsinki Time (GMT +2) Water solubility: Water solubility
More informationDossier Quality Assistant
Overview of DQA rules 6 March 2014 Dossier Quality Assistant This document gives an overview of the rules covered by the Dossier Quality Assistant (DQA), which is incorporated in the IUCLID Validation
More informationWebinar: use of alternative methods to animal testing in your REACH registration
Webinar: use of alternative methods to animal testing in your REACH registration Using alternative methods to meet your information requirements 22 September 2016 Kimmo Louekari Evaluation Unit European
More informationRISK MANAGEMENT OPTION ANALYSIS CONCLUSION DOCUMENT
RISK MANAGEMENT OPTION ANALYSIS CONCLUSION DOCUMENT for Substance name: 2,4,6-trimethyl-2,4,6-tris(3,3,3- trifluoropropyl)cyclotrisiloxane, F-D3 EC number: 219-154-7 CAS number: 2374-14-3 Member State(s):
More informationANNEX IX STANDARD INFORMATION REQUIREMENTS FOR SUBSTANCES MANUFACTURED OR IMPORTED IN QUANTITIES OF 100 TONNES OR MORE ( 1 )
29.5.2007 L 136/111 ANNEX IX REQUIREMTS FOR SUBSTANCES MANUFACTURED OR IMPORTED IN QUANTITIES OF 100 TONNES OR MORE ( 1 ) At the level of this Annex, the registrant must submit a proposal and a time schedule
More informationSurvey results - Analysis of higher tier studies submitted without testing proposals
Survey results - Analysis of higher tier studies submitted without testing proposals Submission of higher tier studies on vertebrate animals for REACH registration without a regulatory decision on testing
More informationJustification for the selection of a substance for CoRAP inclusion
Justification for the selection of a substance for CoRAP inclusion Substance Name (Public Name): Chemical Group: Aluminium chloride inorganic mono constituent substance EC Number: 231-208-1 CAS Number:
More informationAnnex II - List of enforceable provisions of REACH and CLP
Annex II - List of enforceable provisions of REACH and CLP The provisions below are listed according to the sections of the main report, together with the Titles of the Regulation in the case of REACH.
More informationGuidance on information requirements and Chemical Safety Assessment. Chapter R.7a: Endpoint specific guidance
DRAFT Chapter R.a: Endpoint specific guidance PUBLIC: Draft Version x.0 xxxx 0 G U I D A N C E Guidance on information requirements and Chemical Safety Assessment Chapter R.a: Endpoint specific guidance
More informationRead-across illustrative example
Part 2 Example 1 Analogue approach: similarity based on breakdown products Annankatu 18, P.O. Box 400, FI-00121 Helsinki, Finland Tel. +58 9 686180 Fax +58 9 68618210 echa.europa.eu 2 Example 1 DISCLAIMER
More informationOfficial Journal of the European Union
1.6.2016 L 144/27 COMMISSION REGULATION (EU) 2016/863 of 31 May 2016 amending Annexes VII and VIII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation,
More informationH4R Consortium - Substance Identification. Monday 27 th April 2015
H4R Consortium - Substance Identification Monday Mike Penman Page 1 Outline H4R Consortium scope Rosin Chemistry basics Substance ID in H4R Common standards and reporting Reference Substances Development
More informationJustification for the selection of a candidate CoRAP substance
Justification for the selection of a candidate CoRAP substance Substance Name (Public Name): Chemical Group: N,N-dicyclohexylbenzothiazole-2-sulphenamide Benzothiazole EC Number: 225-625-8 CAS Number:
More informationHow to bring your registration dossier in compliance with REACH Tips and Hints - Part 5
How to bring your registration dossier in compliance with REACH Tips and Hints - Part 5 Higher Tier Human Health II Norbert Bornatowicz Kimmo Louekari Ulrike Reuter Content of the presentation Endpoints
More informationStakeholders consultations on Info Cards and Brief Profiles
Stakeholders consultations on Info Cards and Brief Profiles Workshop on Substance Brief Profiles 06 November 2014 Janne Kilpinen Tiago Pedrosa Contents 1 st Written Consultation Overview Main topics, main
More informationAPPLICATION FOR AUTHORISATION: ESTABLISHING REFERENCE DNELs FOR 1-BROMOPROPANE (1-BP)
1 (10) Helsinki, 09 September 2016 RAC/38/2016/09 rev 1 Final APPLICATION FOR AUTHORISATION: ESTABLISHING REFERENCE DNELs FOR 1-BROMOPROPANE (1-BP) Background At the 22 nd meeting of the Committee for
More informationCommittee for Risk Assessment RAC. Opinion proposing harmonised classification and labelling at EU level of potassium sorbate
Committee for Risk Assessment RAC Opinion proposing harmonised classification and labelling at EU level of potassium sorbate EC number: 246-376-1 CAS number: 24634-61-5 CLH-O-0000002524-78-03/F Adopted
More informationSTUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: GENERAL APPROACH TO ESTABLISH AN ACUTE REFERENCE DOSE
VICH GL54 (SAFETY) ARfD November 2016 For Implementation at Step 7 STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: GENERAL APPROACH TO ESTABLISH AN ACUTE REFERENCE DOSE (ARfD)
More informationECHA Committee for Risk Assessment: Evaluation of the Classification and Labelling of Glyphosate
ECHA Committee for Risk Assessment: Evaluation of the Classification and Labelling of Glyphosate Tim Bowmer, Committee Chairman Ari Karjalainen, Dossier Manager for Glyphosate 10 May 2017 1 Established
More informationRisk Management Option Analysis Conclusion Document
Risk Management Option Analysis Conclusion Document Substance Name: tributyl O-acetylcitrate (ATBC) EC Number: 201-067-0 CAS Number: 77-90-7 Authority: France Date: August 2016 Version 2.1 October 2015
More informationANNEX XV REPORT AN ASSESSMENT OF WHETHER THE USE OF MUSK XYLENE IN ARTICLES SHOULD BE RESTRICTED IN ACCORDANCE WITH ARTICLE 69(2) OF REACH
ANNEX XV REPORT AN ASSESSMENT OF WHETHER THE USE OF MUSK XYLENE IN ARTICLES SHOULD BE RESTRICTED IN ACCORDANCE WITH ARTICLE 69(2) OF REACH SUBSTANCE NAME(S): musk xylene IUPAC Name(s): 5-tert-butyl-2,4,6-trinitro-m-xylene
More informationDevelopmental neurotoxicity & REACH
Developmental neurotoxicity & REACH Hannele Huuskonen DNT WS 2016 REACH Article 1 The purpose of this Regulation is to ensure a high level of protection of human health and the environment, including the
More informationEC Number: CAS Number: SUPPORT DOCUMENT FOR IDENTIFICATION OF AS A SUBSTANCE OF VERY HIGH CONCERN BECAUSE OF ITS CMR 1 PROPERTIES
Substance Name: N-methylacetamide EC Number: 201-182-6 CAS Number: 79-16-3 SUPPORT DOCUMENT FOR IDENTIFICATION OF N-METHYLACETAMIDE AS A SUBSTANCE OF VERY HIGH CONCERN BECAUSE OF ITS CMR 1 PROPERTIES 1
More informationJustification for the selection of a candidate CoRAP substance UPDATE
Justification for the selection of a candidate CoRAP substance UPDATE Substance Name (Public Name): Chemical Group: Tetrapropylenebenzene Branched alkylbenzenes EC Number: 246-772-4 CAS Number: 25265-78-5
More informationRoom: 0D Centre Albert Borschette Rue Froissart Brussels, Belgium
EUROPEAN COMMISSION ENVIRONMENT DIRECTORATE-GENERAL Circular Economy and Green Growth Sustainable Chemicals DIRECTORATE-GENERAL INTERNAL MARKET, INDUSTRY, ENTREPRENEURSHIP AND SMES Consumer, Environmental
More informationThe effect of REACH implementation on genotoxicity and carcinogenicity testing Jan van Benthem
The effect of REACH implementation on genotoxicity and carcinogenicity testing Jan van Benthem National Institute for Public Health and the Environment Laboratory for Health Protection Research Bilthoven
More informationOfficial Journal of the European Union. (Non-legislative acts) REGULATIONS
21.2.2015 L 50/1 II (Non-legislative acts) REGULATIONS COMMISSION REGULATION (EU) 2015/282 of 20 February 2015 amending Annexes VIII, IX and X to Regulation (EC) No 1907/2006 of the European Parliament
More informationIntroduction to principles of toxicology and risk assessment
Introduction to principles of toxicology and risk assessment SEAC Training Helsinki, 29-30/06/2009 Kimmo Louekari Unit B4, Evaluation Disclaimer: This presentation does not represent ECHA s position on
More informationHow to use new or revised in vitro test methods to address skin sensitisation
How to use new or revised in vitro test methods to address skin sensitisation (Revised in February 2018) WHICH OF THE REACH INFORMATION REQUIREMENTS MAY BE MET WITH THE TEST(S) Annex VII of the REACH Regulation
More informationSubstance Evaluation Conclusion Document EC No SUBSTANCE EVALUATION CONCLUSION. as required by REACH Article 48 and EVALUATION REPORT.
Substance Evaluation Conclusion Document EC No 203-253-7 SUBSTANCE EVALUATION CONCLUSION as required by REACH Article 48 and EVALUATION REPORT for 4-Methylanisole EC No 203-253-7 CAS No 104-93-8 Evaluating
More informationSubstance Evaluation Conclusion document EC No SUBSTANCE EVALUATION CONCLUSION DOCUMENT. as required by REACH Article 48.
SUBSTANCE EVALUATION CONCLUSION DOCUMENT as required by REACH Article 48 for Buta-1,3-diene EC No 203-450-8 CAS No 106-99-0 Evaluating Member State(s): Germany 22 October 2015 Evaluating Member State Competent
More informationCATEGORY 4 - Rosin adduct esters UVCB CATEGORY JUSTIFICATION DOCUMENT
CATEGORY 4 - Rosin adduct esters UVCB CATEGORY JUSTIFICATION DOCUMENT 1.0 CATEGORY DEFINITION AND ITS MEMBERS This document describes the Rosin adduct esters category and its members as per ECHA guidance
More informationCOMMENTS AND RESPONSE TO COMMENTS ON CLH: PROPOSAL AND JUSTIFICATION. Last data extracted on 10/12/2012
COMMENTS AND RESPONSE TO COMMENTS ON CLH: PROPOSAL AND JUSTIFICATION Comments provided during public consultation are made available in this table as submitted by the webform. Please note that the comments
More informationSubstance Evaluation Conclusion document EC No SUBSTANCE EVALUATION CONCLUSION DOCUMENT. as required by REACH Article 48.
SUBSTANCE EVALUATION CONCLUSION DOCUMENT as required by REACH Article 48 for 2-AMINOETHANOL EC No 205-483-3 CAS No 141-43-5 Evaluating Member State(s): UK Dated: September 2016 Evaluating Member State
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
The European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 15 December 2005 EMEA/357981/2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON PROCEDURES
More informationin the ICH Regions Table of Content Annexes to Guideline and 3. Why is Q4B necessary? Q4B Annexes? for Human Use
Frequently Asked Questions Q4B: Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions The Q4B Expert Working Group developed a set of frequently asked questions to help users
More informationCONTACT DETAILS: EUROPEAN CHEMICALS AGENCY. Annankatu 18, P.O. Box 400, Helsinki, Finland. tel: ,
ANNEX XV REPORT AN ASSESSMENT OF WHETHER THE USE OF DIARSENIC TRIOXIDE AND DIARSENIC PENTAOXIDE IN ARTICLES SHOULD BE RESTRICTED IN ACCORDANCE WITH ARTICLE 69(2) OF REACH SUBSTANCE NAME: Diarsenic trioxide
More informationSubstance Name: Silicic acid, lead salt. EC Number: CAS Number: MEMBER STATE COMMITTEE SUPPORT DOCUMENT FOR IDENTIFICATION OF
Substance Name: Silicic acid, lead salt EC Number: 234-363-3 CAS Number: 11120-22-2 MEMBER STATE COMMITTEE SUPPORT DOCUMENT FOR IDENTIFICATION OF SILICIC ACID, LEAD SALT AS A SUBSTANCE OF VERY HIGH CONCERN
More informationOECD QSAR Toolbox v.4.2. An example illustrating RAAF scenario 6 and related assessment elements
OECD QSAR Toolbox v.4.2 An example illustrating RAAF scenario 6 and related assessment elements Outlook Background Objectives Specific Aims Read Across Assessment Framework (RAAF) The exercise Workflow
More informationFÜR RISIKOBEWERTUNG BUNDESINSTITUT
BUNDESINSTITUT FÜR RISIKOBEWERTUNG Legal and Practical Aspects of the Cut-off Criteria for Reproductive Toxic and Endocrine Disrupting Effects for Approval and Classification of Pesticides in Europe Roland
More informationSubstance Name: Sulfurous acid, lead salt, dibasic. EC Number: CAS Number: SUPPORT DOCUMENT FOR IDENTIFICATION OF
Substance Name: Sulfurous acid, lead salt, dibasic EC Number: 263-467-1 CAS Number: 62229-08-7 SUPPORT DOCUMENT FOR IDENTIFICATION OF SULFUROUS ACID, LEAD SALT, DIBASIC AS A SUBSTANCE OF VERY HIGH CONCERN
More information1,1 - iminodipropan-2-ol
Possibility for MSCA Logo] SUBSTANCE EVALUATION CONCLUSION DOCUMENT as required by REACH Article 48 for 1,1 - iminodipropan-2-ol EC No 203-820-9 CAS No 110-97-4 Evaluating Member State(s): Czech Republic
More informationOpenFoodTox and Other Open Source In silico EFSA. Jean Lou Dorne Senior Scientific Officer Scientific Committee and Emerging Risks Unit EFSA
OpenFoodTox and Other Open Source In silico Tools @ EFSA Jean Lou Dorne Senior Scientific Officer Scientific Committee and Emerging Risks Unit EFSA EFSA FCM Network 10 th July 2017 Basic Principles in
More informationReproductive toxicity classification under CLP (Regulation (EC) no 1272/2008 on Classification, Labelling and Packaging of chemicals)
Reproductive toxicity classification under CLP (Regulation (EC) no 1272/2008 on Classification, Labelling and Packaging of chemicals) A satellite workshop to the 45th Annual Meeting of the European Teratology
More informationRisk Management Option Analysis Conclusion Document
Risk Management Option Analysis Conclusion Document Substance Name: Octamethylcyclotetrasiloxane (D4) EC Number: 209-136-7 CAS Number: 556-67-2 Substance Name: Decamethylcyclopentasiloxane (D5) EC Number:
More informationWe are concerned that the focus of the document is on the estrogen, androgen, thyroid, and
Dear Members of the Guidance Document Drafting Group, The Endocrine Society appreciates the opportunity to comment on the draft guidance for identifying endocrine disruptors. Founded in 1916, the Endocrine
More informationDIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 31 March 2004
30.4.2004 Official Journal of the European Union L 136/85 DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004 amending, as regards traditional herbal medicinal products,
More informationPHENOXY HERBICIDES CASE STUDY CONSIDERED IN CONTEXT OF ECHA RAAF
PHENOXY HERBICIDES CASE STUDY CONSIDERED IN CONTEXT OF ECHA RAAF B. van Ravenzwaay, F. Faulhammer, O. Duerr BASF SE, Ludwigshafen, Germany Disclaimer: The assessment document has been prepared to facilitate
More informationANNEX 4 TO FINAL REPORT
European Commission, Joint Research Centre Institute for Health and Consumer Protection Ispra/Italy Examination and assessment of consequences for industry, consumers, human health and the environment
More informationJustification Document for the Selection of a CoRAP Substance
Justification Document for the Selection of a CoRAP Substance Substance Name (public name): Sodium hydroxymethanesulphinate EC Number: 205-739-4 CAS Number: 149-44-0 Authority: NL MSCA Date: 22/03/2016
More informationThe proposed classification is Skin Sens. 1B H317 and the current classification is Skin Sens. 1 H317.
COMMENTS AND RESPONSE TO COMMENTS ON CLH: PROPOSAL AND JUSTIFICATION Comments provided during public consultation are made available in this table as submitted by the webform. Please note that the comments
More informationPublic Assessment Report Scientific discussion. Trelema (lacosamide) SE/H/1648/01-07/DC
Public Assessment Report Scientific discussion Trelema (lacosamide) SE/H/1648/01-07/DC This module reflects the scientific discussion for the approval of Trelema. The procedure was finalised on 2018-03-08.
More informationCOMMISSION REGULATION (EU)
11.3.2011 Official Journal of the European Union L 64/15 COMMISSION REGULATION (EU) No 234/2011 of 10 March 2011 implementing Regulation (EC) No 1331/2008 of the European Parliament and of the Council
More informationOutcome of the pesticides peer review meeting on general recurring issues in mammalian toxicology
TECHNICAL REPORT APPROVED: 25 July 2016 Outcome of the pesticides peer review meeting on general recurring issues in mammalian toxicology Abstract European Food Safety Authority This technical report reflects
More informationIan Indans Regulatory scientist Chemicals Regulation Directorate (CRD)
Health and Safety Executive Ian Indans Regulatory scientist Chemicals Regulation Directorate (CRD) Health and Safety Executive Acute Inhalation Toxicity testing; The 3Rs, Current needs and Future Prospects
More informationWhat is an Infocard? July 2018
What is an Infocard? July 2018 2 What is an Infocard? Disclaimer This publication is solely intended for information purposes and does not necessarily represent the official opinion of the European Chemicals
More informationEMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use 25 October 1999 EMEA/HMPWP/23/99 EMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS UPDATED DRAFT POINTS
More informationExplanatory note. On an opinion proposing harmonised classification and labelling at EU level of. glyphosate (ISO); N-(phosphonomethyl)glycine
Explanatory note On an opinion proposing harmonised classification and labelling at EU level of glyphosate (ISO); N-(phosphonomethyl)glycine EC Number: 213-997-4 CAS Number: 1071-83-6 This note has been
More informationCHEMICAL SAFETY REPORT EXECUTIVE SUMMARY
CHEMICAL SAFETY REPORT EXECUTIVE SUMMARY Substance Name: Potassium methylsilanetriolate EC Number: 250-807-9 CAS Number: 31795-24-1 Registrant s identity: Wacker Chemie AG, Germany 1 CONTENTS 1 IDENTIFIED
More informationEuropean Food Safety Authority (EFSA)
TECHNICAL REPORT APPROVED: 06 April 2017 doi:10.2903/sp.efsa.2017.en-1210 Outcome of the preliminary pesticides peer review meeting on the assessment of endocrine disrupting properties in mammalian toxicology
More informationPublic Assessment Report Scientific discussion. Heracillin, 1 g, film-coated tablet (flucloxacillin) Asp no:
Public Assessment Report Scientific discussion Heracillin, 1 g, film-coated tablet (flucloxacillin) Asp no: 2016-1464 This module reflects the scientific discussion for the approval of Heracillin. The
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use plondon, 20 February 2003 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) APPENDIX TO THE NOTE FOR
More informationGuidance on information requirements and Chemical Safety Assessment. Chapter R.7a: Endpoint specific guidance
Chapter R.a: Endpoint specific guidance Draft Version.0 Public February 0 G U I D A N C E F O R T H E I M P L E M E N T A T I O N O F R E A C H Guidance on information requirements and Chemical Safety
More informationTest guidelines and guidance documents in the field of plant protection products
Test guidelines and guidance documents in the field of plant protection products BfR background information No. 032/2015 of 3 August 2015 The legislator has stipulated binding rules determining which test
More informationJustification Document for the Selection of a CoRAP Substance
Justification Document for the Selection of a CoRAP Substance Group Name: Iron complexes with N,N'-1,2- ethanediylbis{n-[(2- hydroxyphenyl)methyl]glycine} derivatives EC Numbers: 938-828-8, 283-041-9,
More informationComments CLH proposal Cadmium hydroxide
1 Comments CLH proposal Cadmium hydroxide GENERAL COMMENTS: The International Cadmium association (ICdA) welcomes the opportunity to provide its contribution to the public consultation on the proposed
More informationSubstance identity - screening of the registration dossiers
Substance identity - screening of the registration dossiers Missing and unclear information 30 April 2014 Laszlo Majoros European Chemicals Agency Substance identity IT screening campaign Scope defined
More informationNickel : one of the strongest documented metal
Overview on Regulatory Issues with relevance for nickel International Nickel Study Group Environment and Economic Committee Meeting Lisbon April 12, 2011 Nickel : one of the strongest documented metal
More informationOfficial Journal of the European Union L 109/11
19.4.2008 Official Journal of the European Union L 109/11 COMMISSION REGULATION (EC) No 353/2008 of 18 April 2008 establishing implementing rules for applications for authorisation of health claims as
More informationPublic Assessment Report Scientific discussion. Pramipexole Orion (pramipexole) SE/H/1672/01-07/DC
Public Assessment Report Scientific discussion Pramipexole Orion (pramipexole) SE/H/1672/01-07/DC This module reflects the scientific discussion for the approval of Pramipexole Orion. The procedure was
More informationSubstance Evaluation Conclusion document EC No SUBSTANCE EVALUATION CONCLUSION DOCUMENT. as required by REACH Article 48.
SUBSTANCE EVALUATION CONCLUSION DOCUMENT as required by REACH Article 48 for Butanone oxime EC No 202-496-6 CAS No 96-29-7 Evaluating Member State(s): Germany Dated: 18 March 2014 Evaluating Member State
More informationbenzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride (C.I. Basic Violet 3) 1
Substance name: [4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride (C.I. Basic Violet 3) 1 EC number: 208-953-6 CAS number: 548-62-9 MEMBER STATE COMMITTEE
More informationOverview Internal review
Overview Internal review Presentation title: QRM, It s not all about the assessment Track title: Day 1, Session 2 Speaker: Seamus Orr Date / Time: 10 August 2015, 14.30 15.00 Time allotted: 30 minutes
More informationRCS Overview for Iron Pellets
RCS Overview for Iron Pellets Dr Sue Hubbard Impact study possible revision i Carcinogens Directive Proposed OELs for RCS: 005 0.05 mg/m 3-01 0.1 mg/m 3-02 0.2 mg/m 3 Appointed contractors led by the IOM
More informationAPPLICATION FOR AUTHORISATION: ESTABLISHING A REFERENCE DOSE RESPONSE RELATIONSHIP FOR CARCINOGENICITY OF INORGANIC ARSENIC COMPOUNDS
1 (7) Helsinki, 04 December 2013 RAC/27/2013/07 Rev. 1 (Agreed at RAC-27) APPLICATION FOR AUTHORISATION: ESTABLISHING A REFERENCE DOSE RESPONSE RELATIONSHIP FOR CARCINOGENICITY OF INORGANIC ARSENIC COMPOUNDS
More informationSubstance Name: imidazolidine-2-thione (2-imidazoline-2-thiol) EC Number: CAS Number: SUPPORT DOCUMENT FOR IDENTIFICATION OF
Substance Name: imidazolidine-2-thione (2-imidazoline-2-thiol) EC Number: 202-506-9 CAS Number: 96-45-7 SUPPORT DOCUMENT FOR IDENTIFICATION OF IMIDAZOLIDINE-2-THIONE (2-IMIDAZOLINE-2-THIOL) AS A SUBSTANCE
More informationEcopa REACH Animal Use Calculator
european consensus platform on 3R-alternatives Ecopa REACH Animal Use Calculator Karsten Müller & Simon Webb Apply the Same Principle as Today... Data Collection Classification, Labelling and SDS Risk
More informationKEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE
RNI Conseil 2017 Tous droits réservés Toute reproduction interdite sans l'autorisation de l'auteur. KEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE Anne Laure TARDY, PhD
More informationBiocidal Products Committee (BPC)
Biocidal Products Committee (BPC) Opinion on the application for approval of the active substance: Hydrated lime Product type: 2 ECHA/BPC/100/2016 Adopted 14 April 2016 Annankatu 18, P.O. Box 400, FI-00121
More informationDr. Christian Zeine LGC Standards GmbH. Webinar Series 2013 July 2013
The 7 truths of impurities and their reference standards FDA's and other regulators' viewpoints and further stories (Part 1) Dr. Christian Zeine LGC Standards GmbH Webinar Series 2013 July 2013 Quick guide
More informationCommittee for Risk Assessment RAC
ANNEX 2 - COMMENTS AND RESPONSE TO COMMENTS ON CLH PROPSAL ON FUBERIDAZOLE Committee for Risk Assessment RAC Annex 2 Response to comments document (RCOM) to the Opinion proposing harmonised classification
More informationPublic Assessment Report Scientific discussion SE/H/1689/01/DC
Public Assessment Report Scientific discussion Budesonide/Formoterol Sandoz (budesonide, formoterol fumarate dehydrate) SE/H/1689/01/DC This module reflects the scientific discussion for the approval of
More informationBenzothiazole-2-thiol (2-MBT)
SUBSTANCE EVALUATION CONCLUSION DOCUMENT as required by REACH Article 48 for Benzothiazole-2-thiol (2-MBT) EC No 205-736-8 CAS No 149-30-4 Evaluating Member State(s): Germany Dated: 17 March 2014 Evaluating
More informationStatistical analysis of comparative data on composition and agronomic characteristics: new software tool and recurring issues identified
Statistical analysis of comparative data on composition and agronomic characteristics: new software tool and recurring issues identified C. Paoletti*, J. Perry and H. Broll* * EFSA GMO Unit; EFSA GMO Panel
More informationAPPLICATION OF ALTERNATIVE METHODS IN THE REGULATORY ASSESSMENT OF CHEMICAL SAFETY RELATED TO HUMAN SKIN CORROSION & IRRITATION
APPLICATION OF ALTERNATIVE METHODS IN THE REGULATORY ASSESSMENT OF CHEMICAL SAFETY RELATED TO HUMAN SKIN CORROSION & IRRITATION CURRENT STATUS AND FUTURE PROSPECTS Updated Version Final version 21 December
More informationCommittee for Risk Assessment RAC
ANNEX 2 - COMMENTS AND RESPONSE TO COMMENTS ON CLH PROPOSAL ON BENZOIC ACID Committee for Risk Assessment RAC Annex 2 Response s document (RCOM) to the Opinion proposing harmonised classification and labelling
More informationJustification for the selection of a candidate CoRAP substance
Justification for the selection of a candidate CoRAP substance Substance Name (Public name): 2, 2, 2 -nitrilotriethanol EC Number: 203-049-8 CAS Number: 102-71-6 Submitted by: Bureau for Chemical Substances,
More informationNOTE FOR GUIDANCE ON TOXICOKINETICS: THE ASSESSMENT OF SYSTEMIC EXPOSURE IN TOXICITY STUDIES S3A
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE NOTE FOR GUIDANCE ON TOXICOKINETICS: THE ASSESSMENT
More informationSubstance Name: Fatty acids, C16-18, lead salts. EC Number: CAS Number: SUPPORT DOCUMENT FOR IDENTIFICATION OF
Substance Name: Fatty acids, C16-18, lead salts EC Number: 292-966-7 CAS Number: 91031-62-8 SUPPORT DOCUMENT FOR IDENTIFICATION OF FATTY ACIDS, C16-18, LEAD SALTS AS A SUBSTANCE OF VERY HIGH CONCERN BECAUSE
More informationPublic Assessment Report Scientific discussion. Flucloxacillin Orion (flucloxacillin sodium) SE/H/981/03/DC
Public Assessment Report Scientific discussion Flucloxacillin Orion (flucloxacillin sodium) SE/H/981/03/DC This module reflects the scientific discussion for the approval of Flucloxacillin Orion. The procedure
More informationEstablishing the Relevance of Health Hazard Data for GHS Classification: Adverse vs. Non-Adverse
Establishing the Relevance of Health Hazard Data for GHS Classification: Adverse vs. Non-Adverse Robert Roy, Ph.D. SCHC Fall Meeting Diplomate, American Board of Toxicology September 30, 2014 1 Disclaimer
More informationEVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON DISINTEGRATION TEST GENERAL CHAPTER Q4B ANNEX 5(R1)
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
More informationDOSE SELECTION FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS *)
DOSE SELECTION FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS *) Guideline Title Dose Selection for Carcinogenicity Studies of Pharmaceuticals *) Legislative basis Directive 75/318/EEC as amended Date
More informationPublic Assessment Report Scientific discussion. Vixantus (tadalafil) SE/H/1532/01-04/DC
Public Assessment Report Scientific discussion Vixantus (tadalafil) SE/H/1532/01-04/DC This module reflects the scientific discussion for the approval of Vixantus. The procedure was finalised on 2016-04-20.
More informationAnnex XV dossier. PROPOSAL FOR IDENTIFICATION OF A SUBSTANCE AS A CMR CAT 1A OR 1B, PBT, vpvb OR A SUBSTANCE OF AN EQUIVALENT LEVEL OF CONCERN
Annex XV dossier PROPOSAL FOR IDENTIFICATION OF A SUBSTANCE AS A CMR CAT 1A OR 1B, PBT, vpvb OR A SUBSTANCE OF AN EQUIVALENT LEVEL OF CONCERN Substance Name(s): Lead di(acetate) EC Number(s): 206-104-4
More informationE7 Studies in Support of Special Populations: Geriatrics. Questions & Answers. Current version. dated July 6, 2010
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE E7 Studies in Support of Special Populations: Geriatrics & Current version dated July
More informationGuideline on influenza vaccines submission and procedural requirements
1 2 3 October 2014 EMA/56793/2014 Human Medicines Research and Development Support 4 5 6 Guideline on influenza vaccines submission and procedural requirements Regulatory and procedural requirements module
More informationJustification for the selection of a candidate CoRAP substance
Justification for the selection of a candidate CoRAP substance Substance Name (Public Name): Diethyl phthalate Chemical Group: EC Number: 201-550-6 CAS Number: 84-66-2 Submitted by: Germany/Portugal Published:
More information